 Barclays PLC boosted its stake in shares of Crinetics Pharmaceuticals Inc NASDAQ:CRNX by 87.2 in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission SEC. The institutional investor owned 11,198 shares of the companys stock after buying an additional 5,215 shares during the quarter. Barclays PLCs holdings in ... 